ReviewCancers2026

Advances in Multi-Modal Biomarkers for Immunotherapy Response in Non-Small Cell Lung Cancer: ctDNA, Microbiome, and Radiomics.

Turja Chakrabarti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.